Mingteng International Corporation Inc. (the “Company” or “Mingteng International”) (Nasdaq: MTEN), an automotive mold developer and supplier in China, today announced its unaudited financial results for the first half of fiscal year 2025 ended June 30, 2025. Mr.Yingkai Xu, Chairman and Chief Executive Officer of Mingteng International, remarked, “In the first half of fiscal year […]

LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) — Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED) unresponsive to medication, today announced that the first patient has been implanted with its CaverSTIM(TM) therapy in a U.S. pilot study at Johns Hopkins University School of Medicine. The study will

(NASDAQ:CJET), Investors Exercise Option to Scale Investment 50x from Initial $20 Million Offering New York, Oct. 01, 2025 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (NASDAQ: CJET) (“Chijet” or the “Company”) today announced that it has entered into a Memorandum of Understanding (“MOU”) with certain institutional investors for an expanded private placement offering of up

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) GlobeNewswire October 01, 2025 – Expanding clinical experience and safety profile of ziftomenib support its evaluation in combination with approved FLT3 inhibitors in frontline AML – – FLT3 mutations occur

(NASDAQ:CWD), SCOTTSDALE, Ariz., Oct. 01, 2025 (GLOBE NEWSWIRE) — Caliber (Nasdaq: CWD), a diversified alternative real estate and digital asset platform, today named Blake Janover as the third member of its newly established Caliber Crypto Advisory Board (CCAB). This board provides strategic guidance as Caliber executes its Digital Asset Treasury (DAT) Strategy, centered on building

Spur Therapeutics to Present New Clinical Data on Its Gene Therapy Candidate in Gaucher Disease at Upcoming ESGCT Annual Congress GlobeNewswire October 01, 2025 LONDON, Oct. 01, 2025 (GLOBE NEWSWIRE) — Spur Therapeutics today announced it will present new clinical data for avigbagene parvec (FLT201), its Phase 3-ready gene therapy candidate for Gaucher disease, at

(TSX-V:APGO),(OTC US:APGOF),(Other OTC:APGOF),(Frankfurt:6ZF0), VANCOUVER, British Columbia, Oct. 01, 2025 (GLOBE NEWSWIRE) — Apollo Silver Corp. (“Apollo Silver” or the “Company“) (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) is pleased to announce a non-brokered private placement offering of up to 5,800,000 units (the “Units“) of the Company at a price of $3.60 per Unit, for aggregate gross proceeds of up

(TSX:MDNA),(OTC US:MDNAF),(Other OTC:MDNAF), TORONTO and HOUSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer as well as autoimmune and inflammatory diseases, announced today that Dr. Fahar Merchant, President and CEO of Medicenna, will

NEW YORK CITY, NY / ACCESS Newswire / October 1, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Quantum Corporation ("Quantum" or "the Company") (NASDAQ:QMCO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

Washington, D.C., Oct. 01, 2025 (GLOBE NEWSWIRE) — Today is the start of Global Liver Institute's annual #OctoberIs4Livers campaign, a global effort to raise awareness about liver cancer and unite patients, caregivers, and advocates in driving progress and policy change. This year's campaign theme, Know your Risks – Know your Options, underscores the urgent need